Overview
Lukasz Kuzbicki practices practicing medicine in Torun, Poland.
Mr. Kuzbicki is highly rated in 1 condition, according to our data. His clinical expertise encompasses Melanoma, Squamous Cell Skin Carcinoma, and Actinic Keratosis.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lukasz Kuzbicki
Is Lukasz Kuzbicki a top-rated expert for Melanoma?
MediFind is an objective health platform that identifies experts based on real-world data. Lukasz Kuzbicki is classified as an Advanced expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lukasz Kuzbicki participate in research or clinical trials?
Yes. Lukasz Kuzbicki has published 16 articles and abstracts on conditions like Melanoma. You can view a list of Lukasz Kuzbicki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- MelanomaMr. Kuzbicki isAdvanced. Learn about Melanoma.
- Experienced
- Actinic KeratosisMr. Kuzbicki isExperienced. Learn about Actinic Keratosis.
- Squamous Cell Skin CarcinomaMr. Kuzbicki isExperienced. Learn about Squamous Cell Skin Carcinoma.